AA
IMGN

AQR Arbitrage’s Immunogen Inc IMGN Stock Holding History

AQR Arbitrage’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,429,078
Closed -$42.4M – 720
2023
Q4 		$42.4M Buy
+1,429,078
New +$28.5M 1.71% 3

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's IMGN Position: Q1 2024 in Review

AQR Arbitrage sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,429,078 shares — an estimated $42.4M sold.

AQR Arbitrage first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $42.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • AQR Arbitrage reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • AQR Arbitrage sold 1,429,078 Immunogen Inc shares in Q1 2024, an estimated $42.4M.
  • AQR Arbitrage first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • AQR Arbitrage's Immunogen Inc position peaked at $42.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on AQR Arbitrage's 13F filing for Q1 2024, filed 15 May 2024.